Status:
COMPLETED
RCT With Adjuvant Mistletoe Treatment in Gastric Cancer Patients
Lead Sponsor:
Abnoba Gmbh
Conditions:
Gastric Cancer
Eligibility:
All Genders
19-70 years
Phase:
PHASE4
Brief Summary
Evaluation of safety and efficacy of a standardized mistletoe extract (abnobaVISCUM® Quercus, aVQ) in patients with gastric cancer receiving oral chemotherapy.
Eligibility Criteria
Inclusion
- postoperative UICC stage Ib/II gastric carcinoma
- indication for oral chemotherapy with doxifluridine
- ECOG performance status 0 or 1
- normal liver and kidney function
Exclusion
- inability to answer the QoL scales
- concomitant therapy with steroids or biological response modifiers
- individual hypersensitivity to mistletoe preparations
- pregnancy or lactating
- participation in another clinical trial
Key Trial Info
Start Date :
March 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2008
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT01401075
Start Date
March 1 2006
End Date
April 1 2008
Last Update
November 7 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ASAN Medical Center
Seoul, South Korea, 138-736